PRAME and metastatic melanoma: The PReferentially expressed Antigen in Melanoma (PRAME) is a testis-selective cancer testis antigen (CTA) with restricted expression in somatic tissues and preferentially expressed in variety of cancers, including NSCLC, metastatic melanoma, breast cancer, and neuroblastoma [37].